
Stereotactic body radiation therapy (SBRT) is increasingly being used to manage primary and metastatic liver tumors4,5,6. Accurately accounting for respiratory motion is imperative when targeting liver tumors with radiation.
This study demonstrates the feasibility of using hepatobiliary contrast-enhanced 4D MRI to delineate gross liver tumors directly throughout the respiratory cycle. The lower coverage of directly visualized MRI targets in plans generated using standard of care 4D CT-derived targets suggests that the adoption of 4D MRI for motion management may improve radiation treatment of liver lesions and reduce the risk of marginal misses.

